logo
ADVERTISEMENT

New drug shows big promise of once in two months ARVs

First Kenyans received the injections in March. Medics overwhelmed by many people wanting to join trial

image
by The Star

Big-read01 December 2022 - 16:17
ADVERTISEMENT
Dr Cissy Kityo, a Ugandan epidemiologist and medical researcher who is overseeing the trial in Kenya, Uganda and in South Africa. Next is Prof Rena Shah, a Kenyan infectious disease expert at the Aga Khan hospital who is leading the study at the hospital.

Kenyans who are receiving the long-acting ARVs injection once every two months are responding well to the drugs, raising hopes this treatment will be adopted soon.

This is premium content

Subscribe to Continue Reading

Subscription

Help us continue bringing you unbiased news, in-depth investigations, and diverse perspectives. Your subscription keeps our mission alive and empowers us to provide high-quality, trustworthy journalism. Join us today to make a difference!

Already Subscribed? Sign in
ADVERTISEMENT